Natco Pharma Total Debt vs. Shares Outstanding
| NATCOPHARM | 1,463 29.45 1.97% |
For Natco Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Natco Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Natco Pharma Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Natco Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Natco Pharma Limited over time as well as its relative position and ranking within its peers.
Natco |
Natco Pharma Limited Shares Outstanding vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Natco Pharma's current stock value. Our valuation model uses many indicators to compare Natco Pharma value to that of its competitors to determine the firm's financial worth. Natco Pharma Limited is rated top company in total debt category among its peers. It also is considered to be number one stock in shares outstanding category among its peers creating about 0.05 of Shares Outstanding per Total Debt. The ratio of Total Debt to Shares Outstanding for Natco Pharma Limited is roughly 21.56 . The current Common Stock Shares Outstanding is estimated to decrease to about 176.8 M. Comparative valuation analysis is a catch-all model that can be used if you cannot value Natco Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Natco Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Natco Total Debt vs. Competition
Natco Pharma Limited is rated top company in total debt category among its peers. Total debt of Health Care industry is now estimated at about 22.8 Billion. Natco Pharma retains roughly 3.86 Billion in total debt claiming about 17% of equities under Health Care industry.
Natco Shares Outstanding vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Natco Pharma |
| = | 3.86 B |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Natco Pharma |
| = | 179.11 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Natco Shares Outstanding Comparison
Natco Pharma is currently under evaluation in shares outstanding category among its peers.
Natco Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Natco Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Natco Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Natco Pharma's change in net profit over the period of time. It can combine multiple indicators of Natco Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 1.5 B | 1.6 B | |
| Operating Income | 26 B | 27.3 B | |
| Income Before Tax | 16.7 B | 17.6 B | |
| Total Other Income Expense Net | -9.2 B | -8.8 B | |
| Net Income | 13.9 B | 14.6 B | |
| Income Tax Expense | 2.9 B | 3 B | |
| Net Income From Continuing Ops | 13.9 B | 14.6 B | |
| Net Income Applicable To Common Shares | 8.2 B | 4.4 B | |
| Interest Income | 166.8 M | 158.4 M | |
| Net Interest Income | -192 M | -182.4 M | |
| Change To Netincome | -834.3 M | -792.6 M |
Natco Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Natco Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Natco Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Natco Pharma's important profitability drivers and their relationship over time.
Use Natco Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Natco Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Natco Pharma will appreciate offsetting losses from the drop in the long position's value.Natco Pharma Pair Trading
Natco Pharma Limited Pair Trading Analysis
The ability to find closely correlated positions to Natco Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Natco Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Natco Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Natco Pharma Limited to buy it.
The correlation of Natco Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Natco Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Natco Pharma Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Natco Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Natco Pharma position
In addition to having Natco Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Market Neutral Funds Thematic Idea Now
Market Neutral Funds
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Natco Stock
To fully project Natco Pharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Natco Pharma Limited at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Natco Pharma's income statement, its balance sheet, and the statement of cash flows.